Lucy Norris
@lucynortcd.bsky.social
Scientist at Trinity College Dublin. Interests Cancer associated thrombosis. Coagulation activation in ovarian cancer. Co-Editor in Chief of Thrombosis Update.
So delighted to have you with us today ! #LetsGoEngaged
Great to read the roadmap
Today is #WorldCancerDay ~1 in 5 people will develop #cancer in their lifetime Each diagnosis affects not just one person, but families, communities, and futures Grateful today for patients, clinicians, researchers & advocates - and to appreciate that progress depends on acting together #WCD2026
In a recent @thrombosis-update.bsky.social article, the authors show that the Pathfast D-dimer assay is a rapid POC test for determination of D-dimer with good analytical performance. Read more here: sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal
New treatments have greatly improved survival for #cancer patients but they also come with a risk of #thrombosis. In our new review in @jthjournal.bsky.social we explain why. doi.org/10.1016/j.jt... @wardm6tcd.bsky.social @isth.org.
Our recent publication in British Journal of Cancer www.nature.com/articles/s41...
Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination - British Journal of Cancer
British Journal of Cancer - Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination
nature.com
And, if anyone was wondering about the "science leaving Twitter for Bluesky" trend... the first 24h of this paper on altmetric:
Sharing knowledge is a fundamental principle within the scientific community, yet null and negative results are still being underreported. @scurry.bsky.social &co present a roadmap to a solution that has a role for everyone in the scientific community 🧪 #Academicsky #reproducibility plos.io/3VwaU2O
"I want to read research that feels written for me." That line appeared in our workshop zines and stayed with us. Open access doesn’t automatically mean open understanding. Who do you write for? And who might feel left out? #openresearch #publicengagement
Study sheds light on how reams of fake scientific papers are getting into literature New study shows the ways that networks of researchers, editors and journals are cooperating to publish large numbers of fraudulent papers. @niamhordner.bsky.social writes @latimes.com www.latimes.com/science/stor...
Study sheds light on how reams of fake scientific papers are getting into literature
A new study shows the ways that networks of researchers, editors and journals are cooperating to publish large numbers of fraudulent papers.
latimes.com
🔔Reminder for @ISTH.org on-demand registrants: If you purchased on-demand access for the #ISTH2025 Congress, your access ends August 1! Make sure to log in and catch up on the sessions that matter most to you before time runs out: bit.ly/44Ub0FG
Only 5 days left to apply for this position, don't miss out!! If you are a Postdoc and looking for a job don't forget to check out this opportunity @UniversityLeeds below. Deadline for application is the 25th of July. Start date is the 1st of September.
I am excited to announce that I am recruiting a Post Doc to join my team @universityofleeds.bsky.social! If you are interested in #fibrinogen, #microscopy and #thrombosis check this out: jobs.leeds.ac.uk/Vacancy.aspx... Thank you @thebhf.bsky.social for the funding!
A major KI initiative to recruit new assistant professors with outstanding proposals in all areas of medicine, biomedicine and public health. We offer an amazing research environment, great colleagues and generous startup packages. Check it out and get working on your applications! (repost please!)
Applications are now open! We are recruiting 20 Assistant Professors in a wide range of subject areas. We're looking for early-career researchers with strong scientific merits and future potential. 🔗 All positions: ki.se/en/about-ki/...
University of Galway is inviting the public to contribute to a new initiative aimed at exploring important health-related questions and helping shape the future of health research.🩺 Learn more and have your say: www.thepeoplesreview.ie @thepeoplesreview.ie
Safe #PE treatment for #cancer patients? Ultrasound-guided thrombolysis #CDT shows promise! New study in @thrombosis-update.bsky.social found similar low bleeding rates in cancer & non-cancer patients. Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal
If you are still unsure whether to ask for your data to be deleted by 23andMe and any retained samples destroyed, have a read of this article in the New England Journal of Medicine @nejm.org.
Academic folks, here's proof that Bluesky is a great place to post citations. I am also noticing much better traction in general (I post for an academic group; despite a larger following on X there's much more interaction here).
The general trend is crazy. Here is Twitter vs Bluesky volumes for the last week. On some days they are equal in volume.
New publication from our group in @naturecomms.bsky.social led by Gemma Leon @rcsi.bsky.social Thanks to our collaborators at @tcddublin.bsky.social, CHI Crumlin, and to @researchireland.bsky.social and Children’s Health Ireland for funding. Open access link: rdcu.be/d93ds
Tissue factor-dependent colitogenic CD4+ T cell thrombogenicity is regulated by activated protein C signalling
Nature Communications - Patients with inflammatory bowel disease (IBD) have increased risk for venous thromboembolism, but mechanistic insight is still lacking. Using both mouse experimental...
rdcu.be
The recent @thrombosis-update.bsky.social paper presents an overview of public involvement as a whole and specifically reflects on how it has added value, to an international cancer associated thrombosis #CAT research. #ThrJournal @lucynortcd.bsky.social www.sciencedirect.com/science/arti...
We’re Hiring! Cancer Trials Cork at CUH/UCC Cancer Centre seeks a proactive Operations Lead to manage operations, drive compliance & help patients regionally access cutting-edge treatments through clinical trials. Learn more: tinyurl.com/mubbxh5f 🕒 Apply before Friday 31st January 2025
Great start to 2025 with the publication of our work lead by @lucynortcd.bsky.social! Here we report that chemotherapy alters the anticoagulant protein Thrombomodulin and FVIIIc in patients with gynaecological cancers, and tumour tissue FV being decreased in those who had a VTE shorturl.at/nj8eV
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis
Tumour type, treatment and patient related factors contribute to cancer associated venous thromboembolism (VTE), however, the role of each factor and …
shorturl.at
When 14 journals choose to publish the same article simultaneously, you know the topic is important. This is about predatory journals, which are out to catch the inexperienced authors. If you are thinking of submitting a paper following an invitation, read this first. #publishing
Is #cancer associated #thrombosis caused predominantly by the tumour or treatment. #chemotherapy has unique effects on the activated protein C pathway which may be important in VTE occuring during chemotherapy doi.org/10.1016/j.th....
Resignation of the Journal of Human Evolution Editorial Board: We are saddened to announce the resignations of The Joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor. Press release below.
Just because a paper is highly cited, it does not mean it is any good. The hydroxychloroquine paper as treatment of COVID-19 by Didier Raoult made international news, let to 1000s of patients taking an ineffective drug and was cited 3600 times. Retraction story in Nature journal tinyurl.com/ufjahnyd
Controversial COVID study that promoted unproven treatment retracted after four-year saga
Paper on hydroxychloroquine led by French researcher Didier Raoult is second-most-cited study ever to be withdrawn.
tinyurl.com
Here is the editorial commentary by @lucynortcd.bsky.social and Dr. Papadakis on the article by Mateo et al. in @thrombosis-update.bsky.social in which ther authors presented the data from the TESEO registry. Read more here: www.sciencedirect.com/science/arti...
Improving management of catheter related thrombosis (CRT) in cancer patients by incorporating real world data. The value of cancer VTE registries
sciencedirect.com
Inspired by exciting #thrombosis and #hemostasis content you may have seen at @ash-hematology.bsky.social #ASH24? It gets even better at @isth-official.bsky.social #ISTH2025! Get ready and don’t miss to submit your abstracts by January 15! #HemeSky
Abstract Submission for the #ISTH2025 Congress is now Open. Deadline is January 15, 2025! Don't miss showcasing your most exciting research and contribute to advancing the understanding of #thrombosis and #hemostasis on a global scale! https://buff.ly/3B2XFQy @ISTH-official.bsky.social #HemeSky